Catherine Atlan-Gepner

938 total citations
21 papers, 680 citations indexed

About

Catherine Atlan-Gepner is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Catherine Atlan-Gepner has authored 21 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Catherine Atlan-Gepner's work include Diabetes and associated disorders (9 papers), Diabetes Management and Research (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Catherine Atlan-Gepner is often cited by papers focused on Diabetes and associated disorders (9 papers), Diabetes Management and Research (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Catherine Atlan-Gepner collaborates with scholars based in France, Mali and Armenia. Catherine Atlan-Gepner's co-authors include B. Vialettes, Denis Lairon, Christine Juhel, Catherine Defoort, Marc Nicolino, Najiba Lahlou, R. Maréchaud, Christian Boîtard, Pierre Saı̈ and B Charbonnel and has published in prestigious journals such as The Lancet, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Catherine Atlan-Gepner

20 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Atlan-Gepner France 11 293 241 211 137 128 21 680
Ronit Koren Israel 14 266 0.9× 70 0.3× 82 0.4× 128 0.9× 58 0.5× 45 545
S. R. Munn United States 14 157 0.5× 160 0.7× 466 2.2× 117 0.9× 54 0.4× 46 858
Thomas Bastholm Olesen Denmark 13 87 0.3× 188 0.8× 88 0.4× 126 0.9× 155 1.2× 38 610
Rosanna Lampis Italy 11 192 0.7× 427 1.8× 299 1.4× 183 1.3× 228 1.8× 13 881
Apostolos Kaponis Greece 17 148 0.5× 176 0.7× 79 0.4× 103 0.8× 108 0.8× 54 922
Pierre Lefebvre Belgium 4 116 0.4× 93 0.4× 103 0.5× 81 0.6× 26 0.2× 8 341
H. K. Åkerblom Finland 16 761 2.6× 934 3.9× 678 3.2× 62 0.5× 113 0.9× 24 1.1k
Didier Chevenne France 12 146 0.5× 130 0.5× 82 0.4× 83 0.6× 25 0.2× 30 598
R Cipriani Italy 13 49 0.2× 33 0.1× 238 1.1× 81 0.6× 20 0.2× 29 529
Satu Simell Finland 19 543 1.9× 781 3.2× 674 3.2× 289 2.1× 127 1.0× 24 1.2k

Countries citing papers authored by Catherine Atlan-Gepner

Since Specialization
Citations

This map shows the geographic impact of Catherine Atlan-Gepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Atlan-Gepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Atlan-Gepner more than expected).

Fields of papers citing papers by Catherine Atlan-Gepner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Atlan-Gepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Atlan-Gepner. The network helps show where Catherine Atlan-Gepner may publish in the future.

Co-authorship network of co-authors of Catherine Atlan-Gepner

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Atlan-Gepner. A scholar is included among the top collaborators of Catherine Atlan-Gepner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Atlan-Gepner. Catherine Atlan-Gepner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sartor, Catherine, Christine Zandotti, Fanny Romain, et al.. (2002). Disruption of Services in an Internal Medicine Unit Due to a Nosocomial Influenza Outbreak. Infection Control and Hospital Epidemiology. 23(10). 615–619. 102 indexed citations
2.
Defoort, Catherine, H Narbonne, Christine Juhel, et al.. (2001). Acute Hyperinsulinism Modulates Plasma Apolipoprotein B-48 Triglyceride--Rich Lipoproteins in Healthy Subjects During the Postprandial Period. Diabetes. 50(2). 462–469. 67 indexed citations
3.
Atlan-Gepner, Catherine, Brigitte Kahn‐Perlès, Patrick Lécine, et al.. (2000). Specific Deficiency of p56 lck Expression in T Lymphocytes from Type 1 Diabetic Patients. The Journal of Immunology. 165(10). 5874–5883. 28 indexed citations
4.
Chaillous, Lucy, Hervé Lefèvre, Charles Thivolet, et al.. (2000). Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. The Lancet. 356(9229). 545–549. 189 indexed citations
5.
Martin‐Moutôt, Nicole, José Boucraut, Catherine Atlan-Gepner, et al.. (2000). Humoral Immunity Against Glutamic Acid Decarboxylase and Tyrosine Phosphatase IA-2 in Lambert–Eaton Myasthenic Syndrome. Journal of Clinical Immunology. 20(4). 287–293. 9 indexed citations
6.
Vialettes, B., Pascal Reynier, Catherine Atlan-Gepner, et al.. (2000). Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136 → Ser). British Journal Of Nutrition. 83(6). 615–622. 9 indexed citations
7.
Carrère, J., Catherine Atlan-Gepner, Charles Thivolet, et al.. (1999). Serum reg protein level is not related to the beta cell destruction/regeneration process during early phases of diabetogenesis in type I diabetes. European Journal of Endocrinology. 141(4). 368–373. 5 indexed citations
8.
Atlan-Gepner, Catherine, et al.. (1999). Constitutive Impaired TCR/CD3-mediated Activation of T cells in IDDM Patients Co-exist with Normal Co-stimulation Pathways. Journal of Autoimmunity. 13(2). 247–255. 21 indexed citations
9.
Mekki, Nadia, M. Charbonnier, Catherine Atlan-Gepner, et al.. (1999). Influence of Obesity and Body Fat Distribution on Postprandial Lipemia and Triglyceride-Rich Lipoproteins in Adult Women1. The Journal of Clinical Endocrinology & Metabolism. 84(1). 184–191. 124 indexed citations
10.
Atlan-Gepner, Catherine, Marianne Naspetti, René Valéro, et al.. (1999). Disorganization of Thymic Medulla Precedes Evolution Towards Diabetes in Female NOD Mice. Autoimmunity. 31(4). 249–260. 21 indexed citations
11.
Atlan-Gepner, Catherine & B. Vialettes. (1999). [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].. PubMed. 25(2). 177–9.
12.
13.
14.
Atlan-Gepner, Catherine, et al.. (1998). [Food preferences in anorectic girls at the beginning of therapy].. PubMed. 24(3). 262–71. 8 indexed citations
15.
Atlan-Gepner, Catherine, et al.. (1997). Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.. PubMed. 23(5). 386–94. 3 indexed citations
16.
Dufour, Henry, et al.. (1996). [Corticotropic adenoma in slow adrenal insufficiency].. PubMed. 57(2). 111–5. 2 indexed citations
17.
Atlan-Gepner, Catherine, Pierre Bongrand, Catherine Farnarier, et al.. (1996). Insulin-Induced Lipoatrophy in Type I Diabetes: A possible tumor necrosis factor-α-mediated dedifferentiation of adipocytes. Diabetes Care. 19(11). 1283–1285. 33 indexed citations
18.
Atlan-Gepner, Catherine, et al.. (1995). Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.. PubMed. 21(4). 261–8. 10 indexed citations
19.
Vialettes, B., et al.. (1994). [Outlook for the future in the treatment of diabetic retinopathy].. PubMed. 20(2 Pt 2). 229–34. 2 indexed citations
20.
Conte‐Devolx, B., et al.. (1990). [Bone density after iatrogenic subclinical long-term thyrotoxicosis. Measurement by dual photon absorptiometry].. PubMed. 19(37). 1709–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronit Koren Breakdown of academic impact, for papers by S. R. Munn Breakdown of academic impact, for papers by Thomas Bastholm Olesen Breakdown of academic impact, for papers by Rosanna Lampis Breakdown of academic impact, for papers by Apostolos Kaponis Breakdown of academic impact, for papers by Pierre Lefebvre Breakdown of academic impact, for papers by H. K. Åkerblom Breakdown of academic impact, for papers by Didier Chevenne Breakdown of academic impact, for papers by R Cipriani Breakdown of academic impact, for papers by Satu Simell
Rankless by CCL
2026